Supplemental Cash Flow Disclosures (Details) - CAD ($) |
12 Months Ended | ||
|---|---|---|---|
Jan. 31, 2026 |
Jan. 31, 2025 |
Jan. 31, 2024 |
|
| Supplemental disclosures: | |||
| Interest paid | $ 6,660 | $ 31,817 | $ 0 |
| Non-cash investing and financing activities: | |||
| Common shares issued for settlement of amounts due to related parties and accounts payable | 1,349,937 | 19,688 | 0 |
| Common shares of MedMelior issued for settlement of amounts due to related parties | 0 | 284,000 | 0 |
| Brokers' warrants granted as issue costs for convertible debentures | 0 | 14,606 | 0 |
| Common shares and share purchase warrants issued for conversion of debentures and accrued interest | 619,691 | 702,180 | 0 |
| Brokers' warrants granted as share issue costs | $ 0 | $ 0 | $ 45,371 |